Metabolic models predict fotemustine and the combination of eflornithine/rifamycin and adapalene/cannabidiol for the treatment of gliomas.
Saved in:
| Title: | Metabolic models predict fotemustine and the combination of eflornithine/rifamycin and adapalene/cannabidiol for the treatment of gliomas. |
|---|---|
| Authors: | Kishk, Ali1 (AUTHOR), Pacheco, Maria Pires1 (AUTHOR), Heurtaux, Tony1,2 (AUTHOR), Sauter, Thomas1 (AUTHOR) Thomas.Sauter@uni.lu |
| Source: | Briefings in Bioinformatics. May2024, Vol. 25 Issue 3, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
